Why did small cap stock Sequent Scientific hit the 20% circuit high today?
Bulls favored small-cap stocks Sequent Scientific, despite broader markets being under pressure Thursday. Sequent saw a strong rally that was close to a month high, even hitting its 20% upper circuit. The reason behind the sharp increase in Sequent comes after the company decided not to acquire a 100% stake in Tineta Pharma.
capCircuitConsecutive scientific Tineta newshighhitscientificSequentSequent scientific stock performanceSequent Scientific stock priceSequent Scientific StocksSequent Scientific Tineta AcquisitionSequent Scientific upper circuitsmallstockTodaywhy Sequent Scientific's stock rose
Joanna Swanson is Europe correspondent at the Thomson Reuters Foundation based in Brussels covering politics, culture, business, climate change, society, economies and inclusive tech. With specific focus in breaking news, she has covered some of the world's most significant stories.